M, L., A, T., S, H., T, D., & ON, K. (2023). Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma. Oncology reports, 49(6), . https://doi.org/10.3892/or.2023.8562
Chicago Style (17th ed.) CitationM, Lukoseviciute, Theodosopoulou A, Holzhauser S, Dalianis T, and Kostopoulou ON. "Combination of PARP and WEE1 Inhibitors In vitro: Potential for Use in the Treatment of SHH Medulloblastoma." Oncology Reports 49, no. 6 (2023). https://doi.org/10.3892/or.2023.8562.
MLA (9th ed.) CitationM, Lukoseviciute, et al. "Combination of PARP and WEE1 Inhibitors In vitro: Potential for Use in the Treatment of SHH Medulloblastoma." Oncology Reports, vol. 49, no. 6, 2023, https://doi.org/10.3892/or.2023.8562.